{"version":"1.0","provider_name":"European Scientist","provider_url":"https:\/\/www.europeanscientist.com\/en\/","author_name":"Alex Reis","author_url":"https:\/\/www.europeanscientist.com\/en\/author\/alex-reis\/","title":"Testing antivirals to treat cases of monkeypox","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"OOCWGVOeop\"><a href=\"https:\/\/www.europeanscientist.com\/en\/public-health\/testing-antivirals-to-treat-cases-of-monkeypox\/\">Testing antivirals to treat cases of monkeypox<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.europeanscientist.com\/en\/public-health\/testing-antivirals-to-treat-cases-of-monkeypox\/embed\/#?secret=OOCWGVOeop\" width=\"600\" height=\"338\" title=\"&#8220;Testing antivirals to treat cases of monkeypox&#8221; &#8212; European Scientist\" data-secret=\"OOCWGVOeop\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.europeanscientist.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.europeanscientist.com\/wp-content\/uploads\/2022\/05\/BBB3D59C-1960-48AD-86ED-4EAB7AA6F314.jpeg","thumbnail_width":1280,"thumbnail_height":853,"description":"Some antiviral medications may be able to shorten symptoms and reduce the amount of time a patient with monkeypox is contagious, according to a study published in The Lancet Infectious Diseases journal. The study examined seven patients diagnosed with monkeypox in the UK between 2018 and 2021, representing some of the first known transmission cases outside of Africa."}